Pancreatic Cancer Research

ResearcherIndiana University HealthNo recent work listed

John M. DeWitt

Matched on ORCID iD 0000-0003-3835-4464; OpenAlex author ID A5046731352, A5113587411. Sources: ClinicalTrials.gov.

Their work

Papers
9 (first author 1, last author 3)
Trials
3 (principal investigator on 3)
Grants
0
Labs led
1
Collaborators
23
Papers, trials and grants by year

2009: 2 trials · 2010: none · 2011: 2 papers · 2012: none · 2013: 1 paper, 1 trial · 2014: 3 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 9

  1. A Combined DNA/RNA-based Next-Generation Sequencing Platform to Improve the Classification of Pancreatic Cysts and Early Detection of Pancreatic Cancer Arising… Co-author DOI 10.1097/sla.0000000000005904↗
  2. Combined Versus Separate Sessions of Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for the Diagnosis and Management of Pancreatic Du… Co-author DOI 10.1007/s10620-020-06564-0↗
  3. Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer. Co-author DOI 10.1016/j.gie.2018.09.007↗
  4. Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic ca… Co-author DOI 10.1016/j.ijrobp.2014.02.024↗
  5. Contribution of environment and genetics to pancreatic cancer susceptibility. Co-author DOI 10.1371/journal.pone.0090052↗
  6. EUS-guided celiac plexus interventions in pancreatic cancer pain: An update and controversies for the endosonographer. Last author DOI 10.4103/2303-9027.144515↗
  7. Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis in Pancreatic Cancer: A Prospective Pilot Study of Safety Using 10 mL versus 20 mL Alcohol. Last author DOI 10.1155/2013/327036↗
  8. A prospective, randomized study of EUS-guided celiac plexus neurolysis for pancreatic cancer: one injection or two? Last author DOI 10.1016/j.gie.2011.07.073↗
  9. EUS-FNA mutational analysis in differentiating autoimmune pancreatitis and pancreatic cancer. First author DOI 10.1159/000331505↗

Trials 3

  1. Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer Principal investigator NCT01770132↗
  2. Prevalence of Pancreatic Cysts During Routine Endoscopic Ultra Sound Principal investigator NCT01624363↗
  3. Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts Principal investigator NCT01643460↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stuart Sherman · 3 shared papers, 2011–2021 · strength 0.18
  2. Mohammad Al‐Haddad · 3 shared papers, 2011–2021 · strength 0.18
  3. Safi Shahda · 2 shared papers, 2014–2019 · strength 0.13
  4. Kumaresan Sandrasegaran · 2 shared papers, 2014–2019 · strength 0.13
  5. Ihab I. El Hajj · 1 shared paper, 2021 · strength 0.12
  6. Jeffrey J. Easler · 1 shared paper, 2021 · strength 0.12
  7. Tuğrul Pürnak · 1 shared paper, 2021 · strength 0.12
  8. Evan L Fogel · 1 shared paper, 2021 · strength 0.12
  9. Amikar Sehdev · 1 shared paper, 2019 · strength 0.09
  10. Bert H. O’Neil · 1 shared paper, 2019 · strength 0.09
  11. Michael Garrett House · 1 shared paper, 2019 · strength 0.09
  12. Nicholas Joseph Zyromski · 1 shared paper, 2019 · strength 0.09
  13. Patrick Joseph Loehrer · 2 shared papers, 2014 · strength 0.07
  14. Elena Gabriela Chiorean · 2 shared papers, 2014 · strength 0.07
  15. LeticiaPerondi Luz · 1 shared paper, 2014 · strength 0.07
  16. Julia LeBlanc · 2 shared papers, 2011–2013 · strength 0.06
  17. Barbara A. Hocevar · 1 shared paper, 2014 · strength 0.04
  18. Lisa M. Kamendulis · 1 shared paper, 2014 · strength 0.04
  19. Romnee S. Clark · 1 shared paper, 2014 · strength 0.03
  20. Higinia Rosa Cardenes · 1 shared paper, 2014 · strength 0.03
  21. Asif Khalid · 1 shared paper, 2011 · strength 0.03
  22. Marina N. Nikiforova · 1 shared paper, 2011 · strength 0.03
  23. Keith D. Lillemoe · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.